Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process
Introduction
Aortic valve stenosis (AS) is the most common heart valve disease in western countries and its prevalence steadily increases with age [1], [2]. Given the poor outcome of AS when symptoms develop [3], [4], current guidelines recommend aortic valve replacement (AVR) in patients (pts) with severe, symptomatic AS [5], [6]. Recently, along with surgical replacement, transcatheter AVR through aortic bioprosthesis implantation has been proposed [7]. However, a large number of pts with severe AS, especially the elderly, are denied AVR and still remain untreated [8] because of a high risk of perioperative mortality, as evaluated by several risk score algorithms (EuroSCORE, STS and Parsonnet score) based on individual preoperative cardiac and noncardiac status [9], [10]. As a matter of fact, several comorbidities and concomitant cardiac diseases may contribute to prognosis of hemodynamically significant AS [11], [12], [13]. To our knowledge, the few published data regarding the cardiac and extracardiac conditions associated with AS are focused on specific clinical features and selected group of pts [13], [14], [15], [16], [17]. Accordingly, the aim of the present study was to assess the “global” risk profile of a group of consecutive pts with AS, focusing on the prevalence of comorbidities and coexisting cardiac diseases and their relevance in decision-making process.
Section snippets
Methods
The study population consists of 240 consecutive pts with aortic valve stenosis admitted to our Cardiology Division for clinical–instrumental evaluation over a 12-month period. At the admission, all pts underwent detailed clinical history, physical examination, blood sample, electrocardiogram, chest radiogram, and Doppler-echocardiogram. All other instrumental examinations for the assessment of major comorbidities and associated cardiac diseases were also made as needed (see below). Written
Results
Demographic and clinical characteristics of pts included in this study are summarized in Table 1. Mean age was over 78 years and one fourth of pts was older than 85 years, while only 19 pts (7.9%) were younger than 65 years. According to the body mass index (BMI) > 30 kg/m2, 10% of pts were obese. At the admission 226 pts (94.2%) were symptomatic for at least one of the typical manifestations (dyspnoea, angina and/or syncope). More than one half of the whole population was in New York Heart
Discussion
The main finding of our study – in which a systematic diagnostic work-up on a large group of adult and elderly pts with AS was performed – was the identification of a relevant prevalence of several comorbidities and/or associated cardiac conditions, with potential therapeutic and prognostic implications. These results allow several comments.
First of all, the high prevalence of older subjects with AS in our study population and the frequent association of valve stenosis with coronary and
Conclusion
In adult and elderly subjects with valve AS, a careful search for comorbidities and associated cardiac conditions through a systematic diagnostic approach appears to be relevant for an accurate risk stratification and the choice of adequate therapeutic strategies. Further data are needed to define the prognostic relevance of this approach.
Acknowledgement
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [33].
References (33)
- et al.
Burden of valvular heart diseases: a population-based study
Lancet
(2006) - et al.
Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis
J Am Coll Cardiol
(2004) - et al.
Society of thoracic surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement
Ann Thorac Surg
(2009) - et al.
Clinical profile, treatment assignments and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement
Am J Cardiol
(2010) - et al.
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings
Am J Cardiol
(1986) - et al.
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. American Society of Echocardiography Report
J Am Soc Echocardiogr
(2003) - et al.
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy)
Am J Cardiol
(2005) - et al.
Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis
Am J Cardiol
(2008) - et al.
Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis
Ann Thorac Surg
(2006) - et al.
Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European Multicenter study
J Am Coll Cardiol
(2008)